Département des Neurosciences Fondamentales, Université de Lausanne, Rue du Bugnon 9, 1005 Lausanne, Switzerland.
Prog Neurobiol. 2013 Jun;105:24-48. doi: 10.1016/j.pneurobio.2013.03.002. Epub 2013 Apr 6.
There is currently no approved neuroprotective pharmacotherapy for acute conditions such as stroke and cerebral asphyxia. One of the reasons for this may be the multiplicity of cell death mechanisms, because inhibition of a particular mechanism leaves the brain vulnerable to alternative ones. It is therefore essential to understand the different cell death mechanisms and their interactions. We here review the multiple signaling pathways underlying each of the three main morphological types of cell death--apoptosis, autophagic cell death and necrosis--emphasizing their importance in the neuronal death that occurs during cerebral ischemia and hypoxia-ischemia, and we analyze the interactions between the different mechanisms. Finally, we discuss the implications of the multiplicity of cell death mechanisms for the design of neuroprotective strategies.
目前,对于急性病症如中风和脑窒息,还没有经过批准的神经保护药物治疗方法。造成这种情况的原因之一可能是细胞死亡机制的多样性,因为抑制一种特定的机制会使大脑容易受到其他机制的影响。因此,了解不同的细胞死亡机制及其相互作用至关重要。我们在这里回顾了三种主要形态类型的细胞死亡(凋亡、自噬性细胞死亡和坏死)所涉及的多种信号通路,强调了它们在脑缺血和缺氧缺血过程中神经元死亡中的重要性,并分析了不同机制之间的相互作用。最后,我们讨论了细胞死亡机制多样性对神经保护策略设计的影响。